What is Cogstate?
Founded in 1999 and headquartered in New Haven, Connecticut, Cogstate is a prominent cognitive science firm dedicated to refining the measurement of cognition. The company's core mission is to enhance decision-making through advanced cognitive assessment tools. Cogstate's commercialized offerings include rapid, reliable, and user-friendly computerized cognitive tests designed for a range of applications, from clinical trials and academic research to healthcare and brain injury management. Its focus on objective cognitive measurement positions it as a key player in the health technology sector.
How much funding has Cogstate raised?
Cogstate has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Cogstate
PPP
Public-Private Partnership
What's next for Cogstate?
The recent major strategic investment in Cogstate, following its substantial total funding of $2M, indicates a strong confidence from its backers in the company's future trajectory. This capital infusion is expected to fuel further development of its proprietary cognitive assessment technologies, expand its market reach within clinical research and healthcare, and potentially explore new applications for its cognitive measurement solutions. Cogstate is likely to leverage this financing to scale its operations, enhance its data analytics capabilities, and solidify its leadership in the objective cognitive assessment market.
See full Cogstate company page
